Table 1 The baseline characteristics of patients and controls

Male (%)

2(40%)

6 (75%)

6(85.7%)

Female (%)

3(60%)

2 (25%)

1(14.3%)

Age

70.6 ± 4.5

62.9 ± 3.3

56.7 ± 6.9

SBP(mmHg)

138.4 ± 3.0

129.9 ± 5.0

150.4 ± 19.0

DBP(mmHg)

73.2 ± 5.9

80.4 ± 2.9

91.3 ± 13.7

Etiology

DCM (%)

0

8 (100%)

7 (100%)

Laboratory

BUN (mmol/L)

5.26 ± 0.8

6.65 ± 0.3

9.64 ± 2.7

Cr (umol/L)

61.4 ± 5.2

80.8 ± 4.2*

133.7 ± 13.9*#

Cys-c(mg/L)

0.96 ± 0.1

0.99 ± 0.1

1.50 ± 0.2*#

eGFR (ml/min/1.73m²)

141.6 ± 13.4

110.0 ± 5.9*

67.2 ± 5.6*#

NT-proBNP (pg/mL)

58.83 (48.51, 122.7)

1915 (573.6, 3221)*

2452 (1375, 9407)*

Echocardiogram

LAD (mm)

42.2 ± 2.1

47.9 ± 2.2

47.4 ± 2.3

RAD (mm)

36.2 ± 2.7

41.5 ± 2.7

47.4 ± 3.3*

LVDs (mm)

31.6 ± 1.0

54.8 ± 2.0*

51.7 ± 3.9*

LVDd (mm)

47.6 ± 1.7

67.9 ± 2.2*

70.4 ± 2.5*

LVEF (%)

62.0 ± 0.4

38.0 ± 1.8*

41.0 ± 2.8*